ArticleFrontiers in immunology2021

Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147.

Devy Zisman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.